NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/23/2025
Back to search
Official data from USPTO
SURGICAL SPECIALTIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SURGICAL SPECIALTIES
ST13
US500000086953281Class
10
Filing
86953281
Registration
5510108
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
04/24/2025
Trademark type
Word
Nice classes
10
Filing date
03/25/2016
Registration date
07/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2025
Last transaction
04/24/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
1997-00-00
First use in commerce
1997-00-00
Drawing code
4
Owner type
03
Owner location
Braintree, MA
Examiner
CHADAB, SETH
Current location
Historical data usage
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Kevin S. Costanza SEED IP LAW GROUP LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Sutures
Publications
History of USPTO decisions and trademark events.
46 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/23/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2025
ES8R
TEAS SECTION 8 RECEIVED
10/31/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/03/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/10/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/03/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/30/2018
EXPT
EXPARTE APPEAL TERMINATED
05/18/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/18/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
12/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/11/2017
GNRT
NON-FINAL ACTION E-MAILED
12/11/2017
CNRT
NON-FINAL ACTION WRITTEN
12/11/2017
IUAA
USE AMENDMENT ACCEPTED
12/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2017
ALIE
ASSIGNED TO LIE
11/30/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/20/2017
EXPI
EX PARTE APPEAL-INSTITUTED
11/20/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/20/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/20/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/21/2017
GNFR
FINAL REFUSAL E-MAILED
05/21/2017
CNFR
FINAL REFUSAL WRITTEN
05/21/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2017
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/28/2017
IUAF
USE AMENDMENT FILED
04/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2017
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/27/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2016
GNRT
NON-FINAL ACTION E-MAILED
11/07/2016
CNRT
NON-FINAL ACTION WRITTEN
11/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/13/2016
GNRT
NON-FINAL ACTION E-MAILED
04/13/2016
CNRT
NON-FINAL ACTION WRITTEN
04/13/2016
DOCK
ASSIGNED TO EXAMINER
04/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2016
NWAP
NEW APPLICATION ENTERED
03/29/2016
Continuous trademark protection
Get notified about every new filing that threatens SURGICAL SPECIALTIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.